首页 | 本学科首页   官方微博 | 高级检索  
     

刍议中医药临床研究伦理审查平台建设
引用本文:刘建忠 涂远超 张 馨. 刍议中医药临床研究伦理审查平台建设[J]. 世界中医药, 2013, 8(2): 209-211
作者姓名:刘建忠 涂远超 张 馨
作者单位:湖北省中医院伦理委员会,武汉,430061
摘    要:
随着伦理审查工作逐渐受到人们的普遍重视,伦理委员会在国内得到了较好的建设。在近年来国际上大力发展伦理审查建设和评估的背景下,寻求一种适合我国国情的伦理审查建设和评估体系显得尤为重要。文章从CMAHRPS评估与SIDCER认证的区别、中医药临床研究伦理审查平台建设的主要内容及特色以及本单位推进中医药伦理审查平台建设的实践与效果三方面对中医药临床研究伦理审查平台建设作了一些粗浅的探讨,向各位专家学者请教。

关 键 词:中医药  临床研究  伦理审查
收稿时间:2012-12-11

Discussion on Construction of Ethics Review Platform for Traditional Chinese Medicine Clinical Researches
Liu Jianzhong,Tu Yuanchao,Zhang Xin. Discussion on Construction of Ethics Review Platform for Traditional Chinese Medicine Clinical Researches[J]. World Chinese Medicine, 2013, 8(2): 209-211
Authors:Liu Jianzhong  Tu Yuanchao  Zhang Xin
Affiliation:(Hubei Province Hospital of Traditional Chinese Medicine, Wuhan 430061, China)
Abstract:
Along with the universal attention on ethics review, Ethics Committees are better constructed in China. Under the circumstances of international development of construction on ethics review, seeking an ethics review and evaluation system suitable to China’s condition is especially important. This paper discussed on the construction of ethics review platform for TCM clinical researches from the aspects of differences with CMAHRPS evaluation and SIDCER recognition, main contents and characters of platform construction, practice and effectiveness of the construction.
Keywords:Traditional Chinese medicine  Clinical researches  Ethics review
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号